Tolerability of Angiotensin-Receptor Blockers in Patients with Intolerance to Angiotensin-Converting Enzyme Inhibitors: A Systematic Review and Meta-Analysis

By Caldeira Daniel   David Cláudio   Sampaio Cristina  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 4, 2012-08 ,pp. : 263-277

Adis International

Access to resources Recommend Favorite

Long-Term Treatment with Angiotensin-Converting Enzyme Inhibitors, Beta-Blockers or a Combination of Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers in Low-Risk Patients after Acute Myocardial Infarction: The ABC Study

By  

Heart Drug, Vol. 1, Iss. 1, 2001-03 ,pp. : 20-25

Karger

Access to resources Recommend Favorite

Angiotensin Converting Enzyme (ACE) Inhibitors and Heart Failure: The Consequences of Underprescribing

By Andersson F.  

PharmacoEconomics, Vol. 15, Iss. 6, 1999-06 ,pp. : 535-550

Adis International

Access to resources Recommend Favorite

Effect of Angiotensin-converting Enzyme Inhibitors on Phenylephrine Responsiveness in Patients with Valvular Heart Disease

By Kwak HJ   Kwak YL   Oh YJ   Shim YH   Kim SH   Hong YW  

The Journal of International Medical Research, Vol. 33, Iss. 2, 2005-03 ,pp. : 150-159

Field House Publishing

Access to resources Recommend Favorite

Targeting the renin–angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

By Kjeldsen Sverre E   Lyle Paulette A   Tershakovec Andrew M   Devereux Richard B   Oparil Suzanne   Dahlöf Björn   de Faire Ulf   Fyhrquist Frej   Ibsen Hans   Kristianson Krister   Lederballe-Pedersen Ole   Lindholm Lars H   Nieminen Markku S   Omvik Per   Wedel Hans  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 729-745

Informa Healthcare

Access to resources Recommend Favorite